Cardisure Flavoured 5 mg Tablets for Dogs
Cardisure Flavoured 5 mg Tablets for Dogs
Authorised
- Pimobendan
Product identification
Medicine name:
Cardisure Flavoured 5 mg Tablets for Dogs
Cardisure 5 mg Tablet
Cardisure 5 mg Comprimé
Cardisure 5 mg Tablette
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan5.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 20 blisters per carton, 5 tablets per blister (Aluminium - Aluminium blister)
- 4 blisters per carton, 5 tablets per blister (Aluminium - Aluminium blister)
- 25 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
- 2 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
- 10 blisters per carton, 5 tablets per blister (Aluminium - Aluminium blister)
- 10 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
- 50 blisters per carton, 5 tablets per blister (Aluminium - Aluminium blister)
- 5 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
- GENERA d.d.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0280/003
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Ireland
-
Italy
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 24/11/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
107729 par.pdf
English (PDF)
Download Published on: 20/06/2022
Updated on: 21/06/2022